Digital healthcare has become one of the most promising fields in the healthcare 2 industry with the widespread popularity of wireless devices such as smartphones.
Abstract
The number of digital healthcare mobile apps on the market is increasing exponentially owing to the development of the mobile network and widespread usage of smartphones. However, only a few of these apps have undergone adequate validation. As with many mobile apps, healthcare apps are generally considered safe to use, making them easy for developers and end-users to exchange them in the marketplace. The existing platforms are not suitable to collect reliable data for evaluating the effectiveness of the apps. Moreover, these platforms only reflect the perspectives of developers and experts, not of end-users. For instance, data collection methods typical of clinical trials are not appropriate for participant-driven assessment of healthcare apps because of their complexity and high cost. Thus, we identified a need for a participant-driven data collection platform for end-users that is interpretable, systematic, and sustainable -as a first step to validate the effectiveness of the apps. To collect reliable data in the participatory trial format, we defined distinct stages for data preparation, storage, and sharing. Interpretable data preparation consists of a protocol database system and semantic feature retrieval method to create a protocol without professional knowledge. Collected data reliability weight calculation belongs to the systematic data storage stage. For sustainable data collection, we integrated the weight method and the future reward distribution function. We validated the methods through statistical tests conducted on 718 human participants. The validation results demonstrate that the methods have significant differences in the comparative experiment and prove that the choice of the right method is essential for reliable data collection. Furthermore, we created a web-based system for our pilot platform to collect reliable data in an integrated pipeline. We validate the platform features with existing clinical and pragmatic trial data collection platforms. In conclusion, we show that the method and 1/33 platform support reliable data collection, forging a path to effectiveness validation of digital healthcare apps.
The increased interest in digital health has led researchers to study the effectiveness 19 of current apps. As a practical example, Pokémon GO, which is a game app based on 20 augmented reality, has positive effects on social interaction: 43.2% of people spent more 21 time with their family [52] . In contrast, a 6-week online intervention experiment has 22 revealed that Headspace, which is a healthcare app for mindfulness by guided 23 meditation, has relatively small effects on mindfulness [71] . The outcome contradicts the 24 results of previous randomized controlled trials for the app [44] . Because of such 25 contradictions, there is a need for a reliable mechanism to identify validated digital 26 health apps [62] . 27 Currently, there is no proper platform that evaluates the effectiveness of an app 28 using a systematic and objective validation method in digital health [62] . In particular, 29 mobile health apps have a very fast development cycle and are low-safety issue 30 technology, which tends to reduce the burden of regulation. As a result, these apps have 31 a direct trade characteristics between developers and end-users. However, the few 32 existing platforms are not suitable to evaluate the effectiveness of the apps in this case. 33 For example, review platforms and guidelines are emerging to solve the problem, but patients. At the last step of the project, the TLS clinical trial team designs the protocol 65 from the collected data of the participants. However, also in this case the creation of the 66 protocol is driven by an expert team, rather than common users. Accordingly, the 67 methods for data collection in clinical trials are not appropriate for participant-driven 68 assessment of healthcare apps (which are exponentially growing) because of their 69 complexity and high cost [24, 94] .
70
A study on the real-world measure of the effectiveness of intervention in broad 71 groups is a pragmatic trial [28] . The data collection platform of a pragmatic trial 72 includes not only EDC but also specialized research tools and general surveys. These 73 data collection platforms can be web-based survey applications, or mailed 74 questionnaires, or specific healthcare apps developed from research kits [8, 12, 15] . 75 Therefore, while the platforms still have the issue of complexity, there is also the 76 possibility of collecting less reliable data. For instance, PatientsLikeMe is a platform 77 that shares experience data for participants to understand possible treatments of 78 particular disease conditions based on the experiences of others [101] . However, 79 PatientsLikeMe does not provide an environment for the public to lead the study 80 preparation, and the platform has no feature to evaluate the reliability of collected data. 81 Another example is Amazon Mechanical Turk (MTurk). MTurk is a crowdsourcing 82 marketplace for the recruitment of research participants and a platform for conducting 83 surveys [73] . However, the platform does not provide any standardized method at the 84 data preparation stage. In other words, the platforms need clinical experts to prepare 85 data collection procedures and system based on their knowledge. MTurk provides a 86 feature to approve or reject an individual worker, but the feature relies on a subjective 87 judgement with obvious objectivity limitations. We found that this platform has no 88 suitable method to measure the reliability of the data collected from the participants. 89 The participatory trial platform allows a public user to create and conduct the platforms because they keep user ratings and reviews in the public domain [3, 35, 66] .
95
Both platforms have free text app reviews and scaled rating functions as a data storage 96 feature. However, the review feature has a natural language processing problem, which 97 is not structural data collection [61] . In other words, the platforms have no simple data 98 preparation method to create a systematic data collection protocol. In addition, the 99 platforms have a possible risk of transfer biases that could affect new reviews and 100 
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ratings, because they expose previously collected data to new participants [72] amounts of data is a crucial function of the participatory trial platforms [43, 49, 92] .
117
Furthermore, unlike drugs, functional foods, and mechanical devices that are difficult to 118 modify after the market launch, healthcare apps can be potentially updated as 119 software [26] . The app features may require iterative evaluation following the upgrade. 120 In summary, a new platform for digital healthcare apps should have a sustainable data 121 collection function.
122
Here, we propose a participant-driven reliable data collection method for 123 participatory trial platforms as a first stage to understand the effectiveness of 124 healthcare apps. The method consists of three steps: understandable data preparation, 125 systematic data storage and sustainable data sharing. We utilize a clinical trial protocol 126 database and a semantic relatedness method for the participatory trial protocol to 127 prepare data collection. We develop a data weight reliability formula that collects data 128 systematically. We propose a future reward distribution function connected to data 129 reliability weight for sustainable collection of data. In the results section, we describe 130 the following experiments to validate the reliable data collection method: comparison to 131 the simplicity of data preparation, data reliability weight validation and future reward 132 distribution effect observation. We report testing on a total of 718 human participants 133 for the experiments. The Institutional Review Board (IRB) of KAIST approved an IRB 134 exemption for the experiments.
135
Moreover, we have developed a web-based pilot platform accessible to the public 136 with real-world data as a crowdsourcing tool based on the citizen science concept. The 137 pilot platform systematically integrates all proposed methods. We conduct case studies 138 on the pilot platform to validate efficient recruitment. To demonstrate the advantages of 139 the proposed platform, we compare the platform functionality to existing platforms. 140 
Definition of Participatory Trial

141
A participatory trial is an expanded form of a human-involved trial in which the public 142 is used to test the effectiveness of products within their daily life. The concept follows 143 crowdsourcing and citizen science in the aspect of data-driven science [40, 53] . The Table 1 [67] . We have defined a participatory trial to ameliorate current trial 151 definitions in modern society.
152
Limited to this manuscript, we also defined the meaning of a word or phrase as 153 following;
154
• Platform: Digital platform, that is an environmental software system associated 155 with each functional part of application programs.
156
• Data preparation: Determining the data collection structure and having the same 157 meaning as designing the protocol.
158
• Data storage: Evaluating collected data to store reliably and to determine the 159 value of the data.
160
• Data sharing: Integrating collected data to share with others and to provide 161 benefit with the data provider. protocols with cosine-similarity [55, 75] . Finally, we integrated the methods into the 211 proposed platform for the participatory trial, so that anyone can create a study to easily 212 determine the effectiveness of a healthcare application. Figure 2 shows the overall 213 procedure of the method. 
Systematic Data Storage
215
The participatory trial platform uses crowdsourcing methods to collect data.
216
Crowdsourcing refers to obtaining data and using it for scientific research through 
Data Preparation
Data Storage Data Sharing Figure 1 . Method overview The method consists of three parts: data preparation, data collection, and data distribution. In data preparation, a creator can devise a new study for the evaluation of an app by searching from the protocol creation method. Next, in data storage, the participants conduct a study, and the platform stores all the participants' replies. At the same time, it collects statistics of the replies and calculates the data reliability weight of each reply. After finishing the study, in data sharing, the platform calculates a future reward depending on each person's reliability of both the participants and the creator and distributes the reward to each of them.
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Protocols
Preparation for data collection Protocol Creation Figure 2 . Data preparation to collect The creator retrieves the previous protocol based on the symptom name of the app to verify effectiveness. Then the creator prepares to collect data on the retrieved protocol and creates the participatory trial protocol for data storing.
8/33
amount of data from the public at a low cost [48, 51] . However, data collected from 220 crowdsourcing is often pointed out to be less reliable than results obtained by 221 systematic approaches [25, 59] . Therefore, devising a method to measure data credibility 222 is the main challenge of the data reliability issue.
223
The primary purpose of this method is reliable data collection and delivery for 224 effectiveness evaluation, which is the next level on the path to validation. To achieve 225 this purpose, we needed a method to guarantee the reliability of input data. Therefore, 226 we proposed a formula to calculate the data reliability weight (DRW) through combined 227 effort measures of input data. providing accurate responses and correctly interpreting the data [42] . The recommended 232 composition of IER is response time, long-string analysis, and individual reliability.
233
Response time (RT) is a method to determine the effort based on execution time [104] . 234 Long-string analysis (LSA) uses intentional long-string patterns to assess the effort of a 235 participant [21] . Individual reliability (IR) divides a pair of data items into two halves 236 and uses the correlation between two halves to determine the normal response [83] . In 237 addition, Huang et al. also presented a single self-report (SR) IER item, which includes 238 empirical usefulness [41] . The SR is a single item for detecting IER, and SR consists of 239 the same 7-point Likert scale [65] . We developed the DRW calculation method based on 240 the IER methods.
241
We calculated DRW idx (X) according to the type of electronic case report form
242
(eCRF) for obtaining DRW (1). f RT , f LSA , f SR and f IR are the indexes of DRW. The 243 created protocol contains eCRFs, and an eCRF is a tool used to collect data from each 244 participant. We provided four types of eCRF as described in Supplementary Table 1 .
245
We calculated DRW from the symptom and data type eCRF. 
We calculated f RT and f LSA for symptom and data type of X. f RT calculates the 252 difference between the start and end time when the participant input the data to X.
253
f LSA uses the length input strings. On the other hand, we calculated f SR and f IR only 254 for the symptom type of X. We did not include the SR and IR item in the data type of 255 X to avoid distortion of the response by the participant on the iterative procedures. To 256 measure whether a participant is attentive while entering data at the end, we placed an 257 item of SR at the end of the symptom type of X. The measured pattern of participants 258 should be similar to the symptom type. To reflect the pattern for f IR , we calculated a 259 Pearson correlation coefficient [30] . r IR is the correlation value of Z and Z (2).
items belonging to X. The number of items in Z and Z is the same. We generated Z
262
and Z so that the correlation is close to one. z m k and z m k are the each item value of 263 X k . K is the number of participants, and k is kth participant of K.
Each index has its cutoff value and calculates the cutoff values for each prepared CRF in a study. In detail, we calculated the mean (µ) value and the standard deviation 266 (σ) to remove outliers. We removed an outlier if it was greater than µ + 3σ or smaller 267 than µ − 3σ. After removing the outliers, we calculated µ and σ . Then, we calculated 268 the cumulative distribution function (CDF) for the values of DRW indexes (3). The one 269 reason for CDF is to find a cutoff value that has the lowest area under the probability 270 density function among the input values. The other reason is to represent random 271 variables of real values whose distribution is unknown using the collected values [13] .
272
Accordingly, we used the CDF values to find the µ and σ again to get a normal 273 distribution. On the distribution, we gained cutoff-value using the z-score for the 274 p-value (default is 0.05). h(X ) return 0 if the normalized input value is smaller than 275 the cutoff value, and 1 if the value is larger than the cutoff value (4). We calculated the 276 DRW indexes with the binary decision function.
We calculated DRW of a participant when we computed all the cutoff values of DRW 278 indexes for each CRFs (5, 6) . N is the number of CRFs assigned to a participant.
279
C DRWi is the number of DRW calculation item counts for each CRF type. Figure 3 280 displays an example calculation procedure for DRW.
Sustainable Data Sharing
282
A reward can drive active participation, which is an intuitive fact. Recent scientific 283 findings support the fact that a reward has an impact on data acquisition [29, 49] . We 284 provided financial future rewards for sustainable data collection as exchangeable 285 cryptocurrency [50, 76] . To give the reward, we developed a study result transfer 286 function that delivers statistical information on the completed study to an external 287 cryptocurrency system (Figure 4 ). The study participants periodically receive 288 cryptocurrency as a reward for their data. The total amount of the reward depends on 289 the external cryptocurrency system. However, the reward is an expected compensation 290 after the end of the study, not an immediate profit. Therefore, we tried to induce 291 sustainable participation with an expectation that active participation will earn high 292 rewards [97] . The expectation established a future reward distribution method to draw 293 continuous management motivation from the creator and the active involvement of 294 participants.
295
We collect rewards per each completed study. R total is 296 R creator + R participants + R system . R are rewards. R creator calculates the reward amount 297 based on the compensation proportion of participants and µ DRW value of the study (7) . 298 If the µ DRW is low, this acts as a kind of penalty. We introduced this to encourage the 299 study creators to create a better plan and stimulate a study.
Here, R participant is that R total substrates R creator (8) . K is the total number of 301 participants. DRW k is the calculated DRW for kth participant. The platform rewards 302 participants for their efforts to input data. A participant receives more rewards if he or 303 she made a more than average effort. Otherwise, the participant gets a lower reward.
304
R system acquire high compensation when the µ DRW is low. We added R system to 305 recover the cost of wasting platform resources when careless participants generated 306 unreliable data. We will use R system as a platform maintenance cost.
The proposed platform is designed for a participatory trial. The characteristic of 309 participatory trial in terms of data collection is that people can become researchers and 310 conduct experiments, systematically collecting data based on crowdsourcing and sharing 311 the results with the public [47, 53] .
312
To achieve this goal, we have developed a platform that integrates all the methods 313 presented above, so that each feature is systematically connected to another. The . Participation and future rewards of the study On participating in the study, the result is posted on the blockchain community (①), and the community provides cryptocurrency to the study (②). The platform distributes the rewards differently depending on the participant's level of involvement after the end of the study (③). Figure 5 . Working logic overview of the platform The platform integrates and connects methods for reliable data collection at all stages of study creation, study conduct, and study analysis. In the study creation stage, the creator can create, modify, and delete the study. When the creator activates the study, it is open to other participants, and they can participate. In the study conduct stage, the creator can collect the data from the participants and can monitor them. In addition, the creator and participants can monitor statistical information related to the study. In the study analysis phase, all data generated after the study is completed will be disclosed to the study creator, the participants, and the anonymous users. This makes data available to the experts and the public. The platform services allow users to prepare, collect, and distribute reliable data at each stage in the integrated environment.
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users can join the study. Participants of the study will be curious about the effectiveness 319 of healthcare apps, so that they are more serious about entering data. Research data 320
and basic information about the study are stored in the blockchain to prevent data 321 falsification in vulnerable systems [76] . The study ends after the predefined duration of 322 the research. Even if the number of participants were not enough to develop a sufficient 323 amount of data, the study would be closed at the pre-set endpoint. Consortium [10, 33] . Finally, we integrated the blockchain system to prevent data 336 falsification for the crowdsourced data collection platform in participatory trials [76] .
337
See the Supplement document for more information on the platform development.
338
6 Results
339
The Also, we conducted the results for a clinical trial, not a participatory trial. In contrast, 365 the interpretable data preparation method we proposed is a publicly available system to 366 apply the above technique from the perspective of a participatory trial. Therefore, we 367 need further validation of whether the proposed method is sufficiently simple for anyone 368 to create an interpretable protocol to prepare data collection.
369
For the validation, we designed an experiment that collects Usefulness, Satisfaction, 370 and Ease of Use (USE) score from human participants to reflect their simplicity 371 experience of the different methods [60] . We recruited human participants who 372 represented general users using MTurk [73] . We used 1.1 expected mean and 1.14 373 expected standard deviation (SD) of the previous USE study [31] . We set a power of 374 95% and a one-sided level of significance of 5% to calculate the number of participants. 375 The number of participants was 20 by adjusting the sample size for t-distribution [23] . 376 The participants of the experiment compare the data preparation function, which is 377 related to protocol creation between the proposed method and the existing expert 378 method. We prepared the data preparation method as a simulation program (PM), and 379 the complicated method used Openclinica 3.14, an open-source EDC program (OC) [14] . 380 Two programs recorded randomly generated ID of participants to identify their test 381 completion. The participants respond to the USE questionnaire, which consists of 30 382 items of 7-point Likert scale for the comparison score and 6 short items for their opinion 383 after each use [60] . We reversed the 7-point Likert scale to make participants 384 concentrate more on the questionnaire [11, 41] . We restored the modified scores in the 385 result calculation. In the experiment description, we only provided an elementary data 386 preparation guide and no detailed manual. We also divided participants into two groups 387 to prevent recall bias occurring in the order of the program usage [72] . We reversed the 388 order of use for each group. Finally, we configured the hardware environment identically 389 on the cloud-computing resources of Amazon web services to only identify software 390 differences [17] .
391
After completing the experiment, we excluded participants who did not complete all 392 USE items, had all the same item values, or skipped the test of method systems. 393 
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Consequently, we could obtain forty-two participants from the combined data set of the 394 two groups. Supplementary data We conducted the descriptive statistics of both 395 methods as four divided dimensions [31] . Accordingly, the 30 USE items broke down as 396 follows: 8 usefulness (UU) items, 11 ease of use (UE) items, 4 ease of learning (UL) 397 items, and 7 satisfaction (US) items. The statistics indicated that the proposed method 398 scores were higher than 5 for all USE dimensions ( Figure 6 and Table 2 ). We also found 399 that scores showed negative skewness for all aspects.
400
As described in Table 2 , the average USE score of PM was 5.548 (SD=0.897), and 401 OC was 4.3 (SD=1.5). We conducted a statistical test to confirm a significant difference 402 between the average scores. To check the USE score's normality, we did the 403 Shapiro-Wilk test [87] . The test result p-value of our score was 0.082, and the compared 404 score was 0.238, which satisfied normality (p ¿ 0.05). Therefore, we did the paired 405 sample t-tests, and the USE score presented significantly higher value in PM than OC, 406 with t = 7.243, p <=.001. Since the four dimensions in USE did not satisfy the 407 normality, we conducted the Wilcoxon signed-rank test [102] . The outcome of the test 408 showed noticeable differences between the two methods in all dimensions (Table 3) .
409
Besides the results, we also found that the participants completed 100% of tasks on 410 PM, while they only generated basic metadata of given tasks on OC. Thus, we concluded 411 that PM is more suitable for understandable data preparation in participatory trials. Table 2 . Descriptive statistics of USE in the proposed data preparation method and existing expert method. Statistical description of proposed data preparation method (P) and existing expert method (O). 7−point of Likert scale scores
412
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Figure 6. Whisker box plots of the dimensions in USE between two groups
The proposed data preparation method (PM) showed higher records than the existing expert method (OC) in all domains of tests.
Data Reliability Weight Validation
414
DRW is a weight that is calculated by incorporating a score to measure the effort spent 415 when a user enters data. We examined the correlation between the Human Intelligent
416
Task Approve Rate (HITAR) of MTurk and DRW to assess whether this score is 417 measured well. The HITAR is a score that evaluates how well a worker is performing 418 tasks assigned by the requestor on MTurk. Consequently, we assumed that a higher
419
HITAR would lead to a higher DRW. To verify this, we performed the following tests. 420 We prepared the first test to confirm that the DRW indexes correlated to HITAR.
421
DRW indexes include response time (RT), long string analysis (LSA), individual
422 reliability (IR), and a self-report (SR) [41, 42] . We intended to organize DRW with 423 empirical DRW indexes for simple calculation in eCRF. Because DRW is a subset of 424 IER, we made a questionnaire to calculate DRW based on detecting IER research [41] . 425 We prepared a questionnaire to contain 60 items of the international personality item 426 pool-neuroticism, extroversion, and openness (IPIP-NEO)-to calculate IR [45] .We 427 also added 8 items of the infrequency IER scale to increase the concentration of 428 participants at the beginning of the test and SR item for DRW score [65, 77] . We placed 429 a self-input HITAR item box at the start of the questionnaire as LSA item. Thus, the 430 questionnaire included 70 items. To calculate the total sample size, we used 0.13 431 expected mean of the paired differences based on the result of our pilot DRW test with 432 a total of 100 participants in MTurk. We set a power of 95%, a one-sided level of 433 significance of 5%, and equal group size for sample size calculation [23] . The calculated 434 sample size was 153 for each group, and the total size was 306. We recruited the 435 participants using MTurk. Workers of MTurk participated in the study as participants. 436 We divided all participants into two groups, with HITAR levels above 95 and below 90. 437 Participants over 95 HITAR needed a record of more than 500 tasks before because the first granted HITAR is 100, and it is a deduction method when the task is 442 not performed well. Participants read the task description posted on MTurk. All 443 settings of the test were identical except for the HITAR levels. The endpoint of the test 444 was set to the recruitment completion time of one of the groups. (Figure 7 (a) ). In more detail, we did a statistical analysis to understand the 451 difference between the two groups. HITAR values correctly, and 6 data of participants remained as ungrouped. Accordingly, 475 we removed the 40 data, and we placed 300 data into 30 groups. To check the 476 effectiveness of the binning, we used an information value (IV) that expressed the 477 overall predictive power [86] . The measured IV value (0.465) was greater than 0.3, and 478 we determined that the binning was good. Based on the binning, collected data showed 479 significant results that indicated a noticeable correlation between DRW and HITAR 480 (Figure 7 (b)-(g) ). DRW and HITAR also presented an interesting correlation score 481 (r=0.696, p ¡ 0.001). In summary, we validated that HITAR correlates with DRW and 482 DRW can be used as a reliability measure. Recent studies have confirmed that systems with immediate virtual rewards have a 485 positive effect on continuous data collection [68, 78] . However, we evaluated the validity 486 of a reward distribution that gives rewards to participants in the future, rather than 487 immediately. We showed the validity as correlation between rewards and DRW.
445
488
Accordingly, we evaluated the following scenario, in which the future reward system of 489 our platform increases the participation rate.
490
We created a simulation environment in MTurk to reduce the observation time in 491 the real world. We agreed that a real-world study of the reward distribution effects 492 would require significant time to collect the data and cases. For example,
493
PatientsLikeMe required approximately 5 years to collect enough cases to show the 494 benefits to communities (which were related to the extent of site use) [101] . Thus, we 495 conducted two tests in the simulation environment. We designed one test that informed 496 about reward distributions in the future (the same as our platform). The other test did 497 not contain this information. The remaining settings were unchanged. For the sample 498 size calculation, we conducted a pilot test with 100 participants in MTurk. We obtained 499 0.11 expected mean of the paired differences and 0.25 SD on the result of the pilot test. 500 Based on the result, we calculated the sample size as 168 per each group to have a 501 power of 95% and a one-sided level of significance of 5% [23] . The total sample size was 502 336. Then, we used a questionnaire as data reliability validation and weights for 503 
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consistency comparison, except for the HITAR. However, we needed to consider the 504 casual observation characteristics of MTurk workers since this experiment had no 505 constraint on HITAR [5] . Therefore, we added five questions that induced to enter as 506 many words as possible in the LSA index of DRW [42] . workers to the test that contained future reward information (RI) and the other 168 to 509 the test without future reward information (NRI). We designed the test to be completed 510 within two hours, and we recorded the test start and end times for each worker as RT. 511 Consequently, we successfully collected data from 336 workers (Supplementary data 3) . 512 First of all, we analyzed the effect of RI on the self-reporting rate by a two-way ANOVA 513 test. Table 6 indicates that the reward condition has interaction with consecutive LSA 514 items and is statistically significant at an alpha level of 0.05 (p = 0.008). In other words, 515 we found that continuously containing long characters in consecutive LSA items on the 516 RI condition, and we inferred that the RI condition improves the rate of self-reporting 517 than NRI condition. Next, we found that the average DRW of RI was 0.605, and the 518 DRW of NRI was 0.472 ( Figure 8 ). Table 5 shows the significant difference between 519 DRW of RI and NRI (p=0.03). Table 5 provides detailed statistical information. DRW index values in Table 5 are CDF 522 converted values to calculate the DRW. The DRW(IR) showed a low average result in
523
RI, but we interpreted that the effect size (0.076) of the index is too low to effect the 524 DRW result in Table 5 . We presumed that this is caused by not controlling workers with 525 HITAR. Interesting cases are found in both RT and LSA. Both indexes showed high
526
average DRW values and a significance difference in Table 7 and provide the 541 details in the following subsections. CORUS has a protocol creation feature as interpretable data preparation that makes it 544 easy for the public to use without the help of experts. In the platform, the creator can 545 utilize the clinical trial protocol database feature according to the semantically related 546 symptom of the effectiveness of healthcare apps. Moreover, the creator can get feedback 547 from the study participants within the community feature, which allows the creator to 548 enhance the protocol in the future. 
Comparison with the pragmatic trial systems
550
The protocol creation feature of CORUS provides understandable and straightforward 551 data preparation for public users. The system features of CORUS helps the users lead a 552 study without expert knowledge. Moreover, CORUS has the DRW feature that 553 automatically calculates the reliability scores collected data for reliable data collection. 554 The scores are an objective value that does not comprise the subjective intention of the 555 study creator. We also developed the scores to evaluate the effectiveness score of apps in 556 further study of data storage phase. 
Comparison with participatory trials
558
We developed CORUS as a participatory trial platform. Data preparation features of 559 CORUS prepare data collection that can perform immediate data analysis.
560
Postprocessing for unformatted data is not necessary on the features. The features 561 minimize the flawed study design bias [72] . Besides DRW, data falsification prevention 562 feature prevents transfer bias by not exposing the collected data to the participants 563 during a study. CORUS, a participant-driven platform, also supports additional analysis 564 for experts. Standardized data distribution is an essential feature for validating the 565 effectiveness of an app. Cryptocurrency is a distinctive participation reward feature of 566 CORUS. We connected CORUS to an external blockchain to encourage participants to 567 share their data continuously. Participants can earn a future reward based on their data. 568 CORUS calculate the participant portion of total cryptocurrency of a study based on 
589
We designed the participatory trial project and posted it on the test platform. In the 590 trial, participants were asked to apply the blue light filters (which blocked 
598
In addition to technical validation, we also validated whether the system could 599 effectively recruit participants to the trial. The duration of participant recruitment was 600 originally scheduled for a month, but the actual rate of recruitment was faster than that. 601 In total, 100 participants were recruited in 21 days. We compared the rate of 602 recruitment in this experiment with those known from previous studies. To denote the 603 rate of recruitment among the trials, the recruitment rate was defined as the number of 604 participants recruited per month (or participants per center per month, in the case of 605 multicenter trials). In 151 traditional clinical trials supported by the United Kingdom's 606 Health Technology Assessment program, the recruitment rate was 0.92 [98] . According 607 to 8 web-based or mobile app-based studies collected from literature databases, an 608 average of 468 participants was recruited over 5 months (recruitment rate = 93.6) [54] . 609 For the platform, the recruitment rate was 142.8. This shows that participant 610 recruitment using the platform was significantly more effective than participant 611 recruitment in traditional clinical trials; it was also competitive with other web-based or 612 mobile app-based studies. At this stage, which was the beginning of the study period, 613 the response rate also tended to increase over time. The response rate increased to 120% 614 on recruitment days 17-18, when many new participants were enrolled, and the 615 response rate remained high for a significant period of time ( Figure 9 [72, 89] . At the stage of data preparation, we included flawed study design, 634 channelling bias and selection bias. We tried to prevent flawed study design by using the 635 existing clinical trial protocols. We minimized channelling bias, which leads to including 636 only specific participants, by placing unconditional eligible criteria that anyone can 637 participate in a study. The editable eligible criteria of a creator such as gender and age 638 is still a matter to consider for the channelling bias. However, the selection bias, which 639 can distort the data tendency, is not considered. This is a difficult problem to solve in 640 the field of web-based data collection [7] . As a solution, we propose the social 641 relationship distance estimation method to keep participants beyond a certain distance. 642 A social network estimation method of participants to calculate a closeness rank among 643 participants is an example method for cutting off a certain distance or less [82] . At the 644 stage of data storage and data sharing, we included interviewer bias and transfer bias. 645 The interviewer bias refers to potential influence on the participants deriving from the 646 data collector. Our data storage method does only involve mechanical data collection 647 functions, so we assumed interviewer bias not to occur. However, we do not have any 648 preventive measure against interviewer bias caused by the study description or the CRF 649 items that a creator manually generates. The solution is to clearly define the digital 650 biomarkers that a creator seeks to evaluate the effectiveness of a digital healthcare 651 app [20] . Further research and consensus from experts are needed to enable it for 652 standardized participatory trial protocols with digital biomarkers. The transfer bias in 653 our method is caused by data exposure at the data storage stage and by possible 654 influence by the stored data on other participants. We prevented this source of bias by 655 preventing the stored data from being exposed during a study. Finally, we did not 656 consider the bias generated at the stage of data analysis because it is out of the scope of 657 this article, which is only dealing with data collection methods.
658
There are additional considerations that may improve our platform. First, the relevance of all data involved in the clinical trial, it will reduce the additional analysis 667 burden for the creator. Second, advanced DRW methods should be developed. For 668 example, the basic DRW can be used to assess the reliability of the input data based 669 only on the length of the input text, as in long-string analysis (LSA). In other words, it 670 cannot consider semantic errors in the input text. Therefore, an advanced method that 671 considers semantic errors in the text is required. In addition, we have a cutoff value 672 calculation problem when the SD is 0 from the collected data of a DRW index. We 673 prevented the problem with a predefined minimum cutoff value on the platform, but we 674 need to improve this approach so that we can actively find cutoff values suitable to the 675 collected data. Third, we will devise an optimal strategy to reduce the cost of running 676 the platform. Fourth, an additional study is required to verify the platform. We plan to 677 conduct a small-scale pilot study to check whether the study results are the same as the 678 verified effects. further improvements and further studies, our platform could be used as a valuable tool 691 to assess the effectiveness of various apps in a cost-effective manner. 692 
conclusion
693
At the first stage of the verification workflow, we proposed the reliable data collection 694 method and platform to assess the effectiveness of digital healthcare apps. We presented 695 a participatory trial concept for a new type of data collection trial that uses voluntary 696 participation of end-users of digital healthcare apps. Then, we described the essential 697 methods of the reliable data collection platform based on the participatory trial concept. 698 Interpretable data preparation methods consisted of a protocol database and a retrieval 699 system to create a protocol without expert knowledge. We validated the simplicity of 700 the methods from compared USE scores between the proposed system and the existing 701 system. We developed a DRW calculation method for systematic data storage. The 702 DRW score showed to be a reliable measure through correlation with HITAR. To 703 achieve sustainable data collection and sharing, we developed a reward distribution 704 method. We indirectly observed the effect of reward using DRW. The effect of reward 705 presented increasing DRW, i.e., it increased the participants' effort toward sustainable 706 data collection. Finally, we implemented a pilot platform, CORUS. CORUS integrated 707 all the methods and essential features for a participatory trial platform. We compared 708 its features with existing platforms in the field of clinical trial, pragmatic trial and 709 participatory trial. We assert that CORUS has all the necessary features to collect 710 reliable data from the users of digital healthcare apps on the path of validation of their 711 effectiveness.
712
Code Availability
713
We provide all the source code at https://github.com/junseokpark/corus upon the 714 publication. The platform is open-source to promote development in the public domain. 715 The repository describes software requirements and distributes a README.MD file.
716
